Moderna Inc (MRNA) News

Farmers in bird flu 'panic' call for UK vaccine plan

https://www.bbc.com/news/articles/crm7d2yv878o

bad news

When Donald Trump unveiled a $500bn plan to spearhead a cancer vaccine, many greeted it as another of his grandiose proposals.

But not Anna Bochenski.

The 53-year-old New Yorker is one of the few people in the world who knows how life-changing the shots can be.

symbol



The administrative worker was told she had just months to live in January 2021 after her aggressive breast cancer returned and stopped responding to treatment.

After a six-year battle with the disease, which included numerous surgeries and 32 brutal rounds of radiation, the cancer had spread to her ribs and spine, where it had become virtually incurable, known as 'metastatic'.

As a last resort, she was enrolled in a clinical trial for an experimental cancer vaccine developed at the famous Mount Sinai hospital in Manhattan.

The vaccine works by melting away the primary tumor and teaches the body to hunt and kill the cells that have spread elsewhere. Within weeks, the tumors in her back and a tennis ball-sized tumor under her armpit disappeared, while a third in her chest shrunk.

Speaking to DailyMail.com this month, almost exactly four years after the vaccine, she said: 'It saved my life. At that time, there was nothing I could do. There was nothing that could treat my cancer.'

Hundreds of experimental cancer vaccines are in production around the world, but President Trump's newly announced artificial intelligence project could be the catalyst that finally brings these shots to the public.

https://www.dailymail.co.uk/health/article-14322495/cancer-vaccine-donald-trump-mrna-cure-tumors.html

Fetterman: RFK Jr.’s nomination in trouble after rocky hearing

Sen. John Fetterman (D-Pa.), who was thought to be open to voting for Robert F. Kennedy Jr.’s nomination to head the Department of Health and Human Services, now says the nominee is in serious trouble after his rocky confirmation hearing.

“I don’t think it went well for him today. I don’t think that was a good one,” he said after Kennedy sparred with Democrats on the Senate Finance Committee over his past statements and stance on vaccines.

Fetterman said after the bruising hearing that he thinks Kennedy’s nomination may be “moot.”

“It’s moot,” he said when asked if he’s still open to voting for Kennedy. “I’m not really sure how much support’s going to emerge after that.”

The Pennsylvania Democrat noted that he’s met with Kennedy twice already.

“I think we can all agree that was really a difficult performance,” he said. “I’m not sure he’ll even make it out of the committee.”

Sen. Michael Bennet (D-Colo.), one of the Democrats who grilled Kennedy at his hearing Wednesday, asked him pointedly about his comments on a podcast that exposure to pesticides could be causing more children to identify as transgender.

Kennedy acknowledged under Bennet’s cross-examination that he “probably did say” that Lyme Disease was a militarily-engineered bioweapon.

Sen. Ron Wyden (D-Ore.), meanwhile, tried to pin down Kennedy on his past views and statements on vaccines in a combative back-and-forth.

“You have a history of trying to take vaccines away from people,” Wyden told him.

RFJ, Jr.’s nomination will be voted on by the Senate Finance Committee, but before that happens, he will appear before the Senate Health, Education, Labor and Pensions Committee for a second round of questioning Thursday.

Sen. Susan Collins (R-Maine), a member of the HELP Committee and a key Senate swing vote, said it’s “premature” for her to say how she will vote.

“I do not make decisions on nominees prior to the public hearings,” she said.

“It’s totally premature to make a decision prior to the [public hearing,]” she added.

https://thehill.com/homenews/senate/5114271-fetterman-rfk-jr-nomination-hearing/

It Took RFK Jr. Just Six Minutes to Lie to Congress

https://www.motherjones.com/politics/2025/01/rfk-jr-confirmation-hearing-vaccines/

As the Senate committee hearings over Robert F. Kennedy Jr.’s nomination to serve as secretary of Health and Human Services kick off Wednesday, opposition to his bid is mounting.


"All we need is a handful of senators," says Dr. Rob Davidson, executive director of Committee to Protect Health Care, a progressive advocacy group that reports gathering more than 18,000 signatures from physicians (though the list hasn't been made public). "They should look at his record and it will absolutely confirm that he is a danger."

let's see what will happen

https://www.npr.org/sections/shots-health-news/2025/01/28/nx-s1-5274744/rfk-confirmation-vaccines-health-secretary

Are vaccines the solution to every problem?

Difficult to know whose side to take

Without the proper information on safety and efficacy.

UK confirms 'rare' human case of bird flu

https://medicalxpress.com/news/2025-01-uk-rare-human-case-bird.html

https://www.nature.com/articles/d41586-025-00245-6

this company controls a monster breakthrough technology,
the financial management of the company has allowed itself to be boxed in the corner by manipulative Wall Street crooks using large warrant issuance to control the shares. Today, we do not even know exactly how many zillions of warrants are outstanding!

The company filings and corporate presentation are grossly outdated

moderna it's another world.

Good luck my friend

The cure to cancer brother🚀🚀🚀
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a leading clinical-stage oncology company committed to using its proprietary platform delivery system to defeat cancer, today announced a strategic expansion of its diverse product portfolio. New capabilities for TransCode’s TTX delivery platform are embodied in the new provisional patent application entitled, “Nanoparticles Comprising Payloads and Their In Vivo Delivery” (U.S. patent application 63/456,602 or the ‘602 application).

The therapeutic potential of RNA in oncology has remained an unrealized promise due to what is believed to be the difficulty in safely and effectively delivering oligonucleotides to tumors. Despite well documented targets that have been shown to be important for cancer onset, progression and recurrence, delivery mechanisms have fallen short in delivering RNA therapeutic payloads due to systemic inflammation, toxicity and the inability to efficiently reach their targets. Additionally, targeted delivery of therapeutic agents outside of RNA approaches has also remained a significant challenge for treatment of many other diseases besides cancer.

The technology disclosed in the ‘602 application represents an expansion of TransCode’s therapeutic delivery platform to include applicability to gene editing by repairing and/or replacement of genes using CRISPR technology and cancer vaccines using messenger RNA (mRNA).

TransCode’s said, “Our scientists have been working to expand the potential of our nanoparticle delivery system for some time in order to overcome the challenges of targeted delivery of therapies in oncology. We believe that by expanding our delivery platform and our resulting product portfolio including CRISPR, mRNA vaccines and potentially other targeted therapies outside of RNA positions the company as a platform delivery company.”

The filing of the ‘602 application directly supports TransCode’s goal of deploying the right therapy for individual cancer patients. If issued, the proposed patent would join other granted patents controlled by TransCode, including US 9,629,812 and EP 2 961 386. As part of its overall patent strategy, TransCode is actively pursuing intellectual property protection for additional components of its discovery engine built around its TTX delivery platform. The TTX platform currently comprises a hemodynamic and metabolic targeting delivery system suitable for deploying a variety of therapeutic candidates including RNAi, pattern recognition receptors, mRNA, gene repair/replacement and radiolabeled therapeutics.

“While our major focus is on advancing TTX-MC138, our lead therapeutic candidate targeting miR-10b, shown to be a master regulator of metastatic cell viability in a number of solid tumor types, we are excited by our platform’s expanded potential to be used more broadly for a variety of therapeutic approaches to relevant documented targets responsible for cancer onset, progression and recurrence. The approach represented by the ’602 application, if successful in development, could expand our ability to deploy the right therapy for individual patients using the therapeutic capabilities our platform offers.”

Donald Trump's most impactful move could be to spearhead the world's first cancer vaccine-

This way, patients with the earliest forms of the disease could be identified and treated before the cancer spreads.
We will be amazed at how quickly we're curing this cancer and that one and heart disease and what this will do for the ability to deliver very high quality healthcare... to cure the diseases at a rapid rapid rate.

Similar experimental mRNA cancer vaccines have been in development since the technology was advanced during the Covid pandemic.

https://www.dailymail.co.uk/health/article-14314159/Trumps-radical-500billion-plan-end-cancer-VACCINE.html

$MRNA let's see what will happen

What is an immune system

Why would it need help

How does it get compromised

Create a problem

Offer solution

What a perpetual

Business plan

Norovirus-A large phase three trial of the shot is underway, with results expected as soon as later this year or 2026. Moderna needs to see a certain number of cases before it can analyze the data and determine how well its vaccine works, putting the timeline in flux. The 25,000-person study is enrolling ahead of schedule, said Doran Fink, Moderna’s clinical therapeutic area head for gastrointestinal and bacterial pathogens.

https://www.modernatx.com/en-US/media-center/all-media/blogs/understanding-norovirus

Donald Trump Backing mRNA Vaccine Project Gets Backlash

https://www.newsweek.com/donald-trump-mrna-vaccine-cure-cancer-ai-2018701

$MRNA

Larry Ellison of Oracle: AI will design mRNA vaccines for every individual person against cancer — making them robotically in 48 hours.

"This is the promise of AI."



In a White House briefing on Tuesday, President Donald Trump unveiled the Stargate Project, a $500 billion private sector initiative led by OpenAI, SoftBank, and Oracle.

https://www.maginative.com/article/softbank-openai-and-oracle-launch-500-billion-ai-infrastructure-initiative/

Avian influenza outbreak in Georgia halts sale of poultry, forces quarantine

Poultry capital of the world


https://www.fox5atlanta.com/news/avian-influenza-outbreak-georgia-halts-sale-poultry-forces-quarantine

Moderna is preparing to advance mRNA-1018 into Phase 3. The Company looks forward to sharing the Phase 1/2 results at an upcoming scientific meeting.

Moderna Announces Updates on Pandemic Influenza Program

US awards Moderna $590 million for bird flu vaccine development

I didn't expect it honestly, wasn't mrna technology very bad?! 😅

https://investors.modernatx.com/news/news-details/2025/Moderna-Announces-Updates-on-Pandemic-Influenza-Program/default.aspx

Government starting new virus MRNA When you can’t beat them, you join them🤑🤑🤑🤑

https://www.benzinga.com/insights/analyst-ratings/25/01/43012803/moderna-stock-a-deep-dive-into-analyst-perspectives-10-ratings

U.S. to create new Bird Flu vaccine reserve

https://avinews.com/en/u-s-to-create-new-bird-flu-vaccine-reserve/

Bird flu is mutating, but antivirals still work for now

https://medicalxpress.com/news/2025-01-bird-flu-mutating-antivirals.html

Sounds like the Strawman

In

The Wizard of OZ Is Moderna Stock a No-Brainer Buy on the Sell-Off------------------------

https://www.fool.com/investing/2025/01/15/is-moderna-stock-a-no-brainer-buy-on-the-sell-off/

Is Moderna Stock a No-Brainer Buy on the Sell-Off------------------------

https://www.fool.com/investing/2025/01/15/is-moderna-stock-a-no-brainer-buy-on-the-sell-off/

Mayo Clinic Minute: How personalized vaccines target cancer tumors


https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-how-personalized-vaccines-target-cancer-tumors/

What stomach bug?

Fear card gets old

After awhile Why Is There No Vaccine For Norovirus As It Spreads Across US? How Much Do You Need To Wait ?
Among the most promising is the vaccine candidate from Moderna—currently being tested in human participants, says Health.com

https://www.timesnownews.com/health/why-is-there-no-vaccine-for-norovirus-as-it-spreads-across-us-how-much-do-you-need-to-wait-article-117156931

Another perspective

Saying the same thing

Anyone disagree

Comments welcome

Uncompromised immune system

Would do just fine

If left alone How close are we to a norovirus vaccine?
A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year

https://theweek.com/health/norovirus-vaccine-progress-moderna-science-health

Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited)

Updates 2025 expected revenue range to $1.5 to 2.5 billion

Expects to reduce 2025 cash cost expenses by $1.0 billion with a plan for additional 2026 cost reductions of $0.5 billion

Updates 2025 expected ending cash balance to approximately $6.0 billion

Anticipates milestones across 10 prioritized programs, including up to three potential 2025 approvals and six registrational data readouts

Moderna, Inc. $MRNA Total Debt (mrq) $1.36B

https://news.modernatx.com/news/news-details/2025/Moderna-Provides-Business-and-Pipeline-Updates-at-43rd-Annual-J.P.-Morgan-Healthcare-Conference/default.aspx

Why Is There No Vaccine For Norovirus As It Spreads Across US? How Much Do You Need To Wait ?
Among the most promising is the vaccine candidate from Moderna—currently being tested in human participants, says Health.com

https://www.timesnownews.com/health/why-is-there-no-vaccine-for-norovirus-as-it-spreads-across-us-how-much-do-you-need-to-wait-article-117156931

How close are we to a norovirus vaccine?
A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year

https://theweek.com/health/norovirus-vaccine-progress-moderna-science-health

It provides hope’: Groundbreaking vaccine being developed to target deadliest form of breast cancer

One day, it might be possible to eliminate breast cancer as a disease,” said Dr. Amit Kumar, the Chairman & CEO of Anixa Biosciences, who helped develop the vaccine.

https://www.wrtv.com/health/it-provides-hope-groundbreaking-vaccine-being-developed-to-target-deadliest-form-of-breast-cancer

$ANIX

The Future Of mRNA Cancer Vaccines Looks Commercially Viable

https://www.biospace.com/press-releases/the-future-of-mrna-cancer-vaccines-looks-commercially-viable

Highest Phase Of Clinical Trials: Phase III ( 2 Vaccine)
mRNA 4157

https://www.kuickresearch.com/report-mrna-cancer-vaccine-rnca-vaccine-mrna-cancer-vaccine-market-fda-approved-mrna-cancer-vaccine-mrna-cancer-vaccine-clinical-trials-mrna-cancer-vaccines

How is this?

A good thing Finally an article on Moderna's factory in China: "Moderna Is Gambling on China as Other U.S. Companies Pull Back" WSJ

https://www.reddit.com/r/ModernaStock/comments/1hx4obe/finally_an_article_on_modernas_factory_in_china/?rdt=47998

Finally an article on Moderna's factory in China: "Moderna Is Gambling on China as Other U.S. Companies Pull Back" WSJ

https://www.reddit.com/r/ModernaStock/comments/1hx4obe/finally_an_article_on_modernas_factory_in_china/?rdt=47998

A study, which was published in the journal Alzheimer’s & Dementia in December 2024, finds a connection between cytomegalovirus (CMV), a common childhood infection, and Alzheimer’s

https://www.womenshealthmag.com/health/a63350776/cmv-alzheimers-disease-study/

https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14401

Please define protocol

Seems triggered

Not quite

There The first interim analysis for the evaluation of vaccine efficacy, which will be triggered when both 81 confirmed per-protocol cases and 12 median months of safety follow-up have occurred

we're almost there

The first interim analysis for the evaluation of vaccine efficacy, which will be triggered when both 81 confirmed per-protocol cases and 12 median months of safety follow-up have occurred

we're almost there

Far reaching

Indeed

Cytomegalovirus (CMV) is the leading cause of infectious birth defects and linked to many other morbidities such as transplantation. For the first time in over 50 years of pursuit, a vaccine is in reach

https://www.jci.org/articles/view/182317

https://www.jci.org/articles/view/182317/table/1

What happens when current belief systems

Are turned on its head

Initial response

Disbelief

Normalcy bias

Cognitive dissonance

Or

Stockholm syndrome

All prevent critical thought

Has it been tested on humans?

What is in this vaccine?

All the ingredients

What the industry is doing

Is important

Relating to Moderna

Bigger picture

Outside

Looking in

my friend MODERNA he doesn't need it Of ZIVO

bird flu-
https://www.fiercebiotech.com/research/mrna-vaccine-cdc-and-moderna-protects-ferrets-current-avian-influenza-strain

I get it but when a disease such as Avian flu its the world with no cure and Moderna is the poster board for new cure company one most consider the breadth and strength and nimbleness Moderna could have with the right antidote

we only talk about moderna.

Yeah, they are kinda tight lipped about there proprietary algae strand. But the core compound is used to fight the coccidiosis a leading killer in poultry.
ZIVO would be an easy pick up for Moderna especially with the approvals in place and the first step under taking for the fight against Avian Flu...

This is a good start

Although

Would like to know

All the ingredients

Not just one or two ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza